Launching a Medtech Product? Have Your Regulatory, IP and Governance Affairs in Order Before Engaging Investors

Walter Linder, Amy Judge-Prein and Jonathan Zimmerman authored an article for Medical Alley, exploring the importance of having regulatory, intellectual property and governance affairs matters in order before approaching investors with the a medtech product.

The inability to ensure investors that these matters are properly addressed may slow and complicate the investment process. It may even derail the process all together.Walter Linder, Amy Judge-Prein and Jonathan Zimmerman, Medical Alley